imipramine has been researched along with Infections, Staphylococcal in 2 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Elsebaei, MM | 1 |
Mohammad, H | 1 |
Abouf, M | 1 |
Abutaleb, NS | 2 |
Hegazy, YA | 1 |
Ghiaty, A | 1 |
Chen, L | 1 |
Zhang, J | 1 |
Malwal, SR | 1 |
Oldfield, E | 1 |
Seleem, MN | 2 |
Mayhoub, AS | 2 |
Shahin, IG | 1 |
Alhashimi, M | 1 |
Kassab, AE | 1 |
Mohamed, KO | 1 |
Taher, AT | 1 |
2 other studies available for imipramine and Infections, Staphylococcal
Article | Year |
---|---|
Alkynyl-containing phenylthiazoles: Systemically active antibacterial agents effective against methicillin-resistant Staphylococcus aureus (MRSA).
Topics: Alkynes; Animals; Anti-Bacterial Agents; Half-Life; Methicillin-Resistant Staphylococcus aureus; Mic | 2018 |
Evaluation of N-phenyl-2-aminothiazoles for treatment of multi-drug resistant and intracellular Staphylococcus aureus infections.
Topics: Animals; Anti-Bacterial Agents; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Humans; | 2020 |